株式会社グローバルインフォメーション
TEL: 044-952-0102
SALE
市場調査レポート

再生医療の世界市場 - 予測と機会:2025年

Global Regenerative Medicine Market By Therapy, By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025

発行 TechSci Research 商品コード 934759
出版日 ページ情報 英文 117 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

再生医療の世界市場 - 予測と機会:2025年 Global Regenerative Medicine Market By Therapy, By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025
出版日: 2020年05月01日 ページ情報: 英文 117 Pages
概要

世界の再生医療市場は、細胞、組織、臓器における修復および置換または再生における使用が増加しているため、2025年までCAGRで二桁の成長が予測されています。さらに、慢性的疾患や遺伝的疾患の高率発生、幹細胞技術の出現、高齢化人口の増加などが、再生医療市場を牽引する重要な要因の一部です。

再生医療は、正常な機能を回復または確立するために、ヒトまたは動物の細胞、組織または臓器を置換、操作または再生するプロセスを扱います。それらはまた、永久に損傷を受ける臓器の解決策を生み出すためにも使用されています。これらの医療はまた、関節炎や糖尿病のようないくつかの不治の病の治療にも使用されます。

当レポートでは、世界の再生医療市場について調査分析し、市場規模・シェア・予測、セグメント別分析、競合分析、市場動向の変化、新興の機会について、体系的な情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 世界の再生医療市場に対するCOVID-19 (新型コロナウイルス感染症) の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

第6章 世界の再生医療市場の見通し

  • 市場規模と予測
  • 市場シェアと予測

第7章 北米の再生医療市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 北米:国別分析

第8章 欧州の再生医療市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 欧州:国別分析

第9章 アジア太平洋地域の再生医療市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • アジア太平洋地域:国別分析

第10章 中東・アフリカの再生医療市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 中東・アフリカ:国別分析

第11章 南米の再生医療市場の見通し

  • 市場規模と予測
  • 市場シェアと予測
  • 南米:国別分析

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と動向

第14章 競合情勢

第15章 戦略的提言

第16章 出版社と免責事項

目次
Product Code: 4685

Global regenerative medicine market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function. They are also being used to create solutions for organs that become permanently damaged. These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.

Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The global regenerative medicine market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region. The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others. Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases. Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical. The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.

Major players operating in the global regenerative medicine market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global regenerative medicine market.
  • To classify and forecast global regenerative medicine market based on therapy, application, material, cell, product, technique, distribution channel and regional distribution.
  • To identify drivers and challenges for global regenerative medicine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global regenerative medicine market.
  • To conduct pricing analysis for global regenerative medicine market.
  • To identify and analyze the profile of leading players operating in global regenerative medicine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global regenerative medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Regenerative medicine manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to regenerative medicines
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Therapy:

Cell-Based Immunotherapy & Cell Therapy

Gene Therapy

Tissue-Engineering

Immunomodulation Therapy

Blood Transfusion

Bone Marrow Transplantation

Plasma Rich Plasma Therapy

Prolotherapy

Others

  • Market, By Application:

Musculoskeletal Disorders

Wound Care

Oncology

Neurology

Ocular Disorders

Diabetes

Cardiology

Others

  • Market, By Material:

Synthetic Material

  • Biodegradable Synthetic Polymers
  • Scaffold
  • Artificial Vascular Graft Materials
  • Hydrogel Materials

Biologically Derived Material

  • Collagen
  • Xenogeneic Material

Genetically Engineered Material

  • Genetically Manipulated Cells
  • 3D Polymer Technology
  • Transgenic
  • Fibroblast
  • Neural Stem Cells
  • Gene-activated Matrices

Pharmaceutical

  • Small Molecules
  • Biologics
  • Market, By Cell:

Autologous

Allogenic

  • Market, By Product:

Biologic

Cell -based Medical Devices

Biopharmaceutical

Biomaterial

  • Market, By Technique:

Microfracture

Mosaicplasty

  • Market, By Distribution Channel:

Hospitals

Clinics

Online

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global regenerative medicine market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Regenerative Medicine Market

4. Executive Summary

5. Voice of Customer

6. Global Regenerative Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Tissue-Engineering, Immunomodulation therapy, Blood transfusion, Bone marrow transplantation, Plasma rich plasma therapy, Prolotherapy, Others)
    • 6.2.2. By Application (Musculoskeletal Disorders, Wound Care, Oncology, Neurology, Ocular Disorders, Diabetes, Cardiology, Others)
    • 6.2.3. By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical)
      • 6.2.3.1. By Synthetic Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Materials)
      • 6.2.3.2. By Biologically Derived Material (Collagen, Xenogeneic Material)
      • 6.2.3.3. By Genetically Engineered Material (Genetically Manipulated Cells, 3D Polymer Technology, Transgenic, Fibroblast, Neural Stem Cells, Gene-activated Matrices)
      • 6.2.3.4. By Pharmaceutical (Small Molecules, Biologics)
    • 6.2.4. By Cell (Autologous, Allogenic)
    • 6.2.5. By Product (Biologic, Cell -based Medical Devices, Biopharmaceutical, Biomaterial)
    • 6.2.6. By Technique (Microfracture, Mosaicplasty)
    • 6.2.7. By Distribution Channel (Hospitals, Clinics, Online, Others)
    • 6.2.8. By Region
    • 6.2.9. By Company

7. North America Regenerative Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapy
    • 7.2.2. By Application
    • 7.2.3. By Material
    • 7.2.4. By Cell
    • 7.2.5. By Product
    • 7.2.6. By Technique
    • 7.2.7. By Distribution Channel
    • 7.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Regenerative Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapy
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Material
        • 7.3.1.2.4. By Cell
        • 7.3.1.2.5. By Product
        • 7.3.1.2.6. By Technique
        • 7.3.1.2.7. By Distribution Channel
    • 7.3.2. Canada Regenerative Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapy
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Material
        • 7.3.2.2.4. By Cell
        • 7.3.2.2.5. By Product
        • 7.3.2.2.6. By Technique
        • 7.3.2.2.7. By Distribution Channel
    • 7.3.3. Mexico Regenerative Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapy
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Material
        • 7.3.3.2.4. By Cell
        • 7.3.3.2.5. By Product
        • 7.3.3.2.6. By Technique
        • 7.3.3.2.7. By Distribution Channel

8. Europe Regenerative Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapy
    • 8.2.2. By Application
    • 8.2.3. By Material
    • 8.2.4. By Cell
    • 8.2.5. By Product
    • 8.2.6. By Technique
    • 8.2.7. By Distribution Channel
    • 8.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Regenerative Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapy
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Material
        • 8.3.1.2.4. By Cell
        • 8.3.1.2.5. By Product
        • 8.3.1.2.6. By Technique
        • 8.3.1.2.7. By Distribution Channel
    • 8.3.2. Germany Regenerative Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapy
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Material
        • 8.3.2.2.4. By Cell
        • 8.3.2.2.5. By Product
        • 8.3.2.2.6. By Technique
        • 8.3.2.2.7. By Distribution Channel
    • 8.3.3. United Kingdom Regenerative Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapy
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Material
        • 8.3.3.2.4. By Cell
        • 8.3.3.2.5. By Product
        • 8.3.3.2.6. By Technique
        • 8.3.3.2.7. By Distribution Channel
    • 8.3.4. Italy Regenerative Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapy
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Material
        • 8.3.4.2.4. By Cell
        • 8.3.4.2.5. By Product
        • 8.3.4.2.6. By Technique
        • 8.3.4.2.7. By Distribution Channel
    • 8.3.5. Spain Regenerative Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapy
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Material
        • 8.3.5.2.4. By Cell
        • 8.3.5.2.5. By Product
        • 8.3.5.2.6. By Technique
        • 8.3.5.2.7. By Distribution Channel

9. Asia-Pacific Regenerative Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapy
    • 9.2.2. By Application
    • 9.2.3. By Material
    • 9.2.4. By Cell
    • 9.2.5. By Product
    • 9.2.6. By Technique
    • 9.2.7. By Distribution Channel
    • 9.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. South Korea Regenerative Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapy
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Material
        • 9.3.1.2.4. By Cell
        • 9.3.1.2.5. By Product
        • 9.3.1.2.6. By Technique
        • 9.3.1.2.7. By Distribution Channel
    • 9.3.2. China Regenerative Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapy
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Material
        • 9.3.2.2.4. By Cell
        • 9.3.2.2.5. By Product
        • 9.3.2.2.6. By Technique
        • 9.3.2.2.7. By Distribution Channel
    • 9.3.3. Japan Regenerative Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapy
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Material
        • 9.3.3.2.4. By Cell
        • 9.3.3.2.5. By Product
        • 9.3.3.2.6. By Technique
        • 9.3.3.2.7. By Distribution Channel
    • 9.3.4. India Regenerative Medicine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value & Volume
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapy
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By Material
        • 9.3.4.2.4. By Cell
        • 9.3.4.2.5. By Product
        • 9.3.4.2.6. By Technique
        • 9.3.4.2.7. By Distribution Channel
    • 9.3.5. Australia Regenerative Medicine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value & Volume
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapy
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By Material
        • 9.3.5.2.4. By Cell
        • 9.3.5.2.5. By Product
        • 9.3.5.2.6. By Technique
        • 9.3.5.2.7. By Distribution Channel

10. Middle East and Africa Printing Ink Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapy
    • 10.2.2. By Application
    • 10.2.3. By Material
    • 10.2.4. By Cell
    • 10.2.5. By Product
    • 10.2.6. By Technique
    • 10.2.7. By Distribution Channel
    • 10.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Regenerative Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapy
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Material
        • 10.3.1.2.4. By Cell
        • 10.3.1.2.5. By Product
        • 10.3.1.2.6. By Technique
        • 10.3.1.2.7. By Distribution Channel
    • 10.3.2. Saudi Arabia Regenerative Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapy
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Material
        • 10.3.2.2.4. By Cell
        • 10.3.2.2.5. By Product
        • 10.3.2.2.6. By Technique
        • 10.3.2.2.7. By Distribution Channel
    • 10.3.3. UAE Regenerative Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapy
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Material
        • 10.3.3.2.4. By Cell
        • 10.3.3.2.5. By Product
        • 10.3.3.2.6. By Technique
        • 10.3.3.2.7. By Distribution Channel

11. South America Regenerative Medicine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapy
    • 11.2.2. By Application
    • 11.2.3. By Material
    • 11.2.4. By Cell
    • 11.2.5. By Product
    • 11.2.6. By Technique
    • 11.2.7. By Distribution Channel
    • 11.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Regenerative Medicine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value & Volume
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapy
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Material
        • 11.3.1.2.4. By Cell
        • 11.3.1.2.5. By Product
        • 11.3.1.2.6. By Technique
        • 11.3.1.2.7. By Distribution Channel
    • 11.3.2. Argentina Regenerative Medicine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value & Volume
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapy
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Material
        • 11.3.2.2.4. By Cell
        • 11.3.2.2.5. By Product
        • 11.3.2.2.6. By Technique
        • 11.3.2.2.7. By Distribution Channel
    • 11.3.3. Colombia Regenerative Medicine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value & Volume
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapy
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Material
        • 11.3.3.2.4. By Cell
        • 11.3.3.2.5. By Product
        • 11.3.3.2.6. By Technique
        • 11.3.3.2.7. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Novartis AG
    • 14.2.2. Vericel
    • 14.2.3. Integra Lifesciences
    • 14.2.4. Mimedx Group
    • 14.2.5. Stryker
    • 14.2.6. Wright Medical
    • 14.2.7. Roche
    • 14.2.8. Bristol-Myers Squibb
    • 14.2.9. Allergan
    • 14.2.10. Corline Biomedical
    • 14.2.11. Cook Biotech
    • 14.2.12. Pfizer
    • 14.2.13. Baxter
    • 14.2.14. Boehringer Ingelheim
    • 14.2.15. Caladrius Biosciences
    • 14.2.16. Takara Bio
    • 14.2.17. Medtronic
    • 14.2.18. Osiris Therapeutics
    • 14.2.19. Kite Pharma
    • 14.2.20. Organogenesis

15. Strategic Recommendations

16. About Us and Disclaimer